Immunocore Holdings (IMCR) Total Current Liabilities (2019 - 2026)

Immunocore Holdings has disclosed Total Current Liabilities across 8 years of filings, most recently posting $240.1 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $240.1 million, up 60.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $240.1 million (up 60.97% YoY), and the FY2025 annual result was $246.7 million, up 16.27% from the prior year.
• Total Current Liabilities came in at $240.1 million for Q1 2026 at Immunocore Holdings, down from $246.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $266.2 million in Q3 2024 to a low of $97.5 million in Q4 2022.
• The 5-year median for Total Current Liabilities is $170.4 million (2025), against an average of $184.7 million.
• Across the five-year window, Total Current Liabilities slumped 36.02% in 2025 and surged 60.97% in 2026, its largest moves.
• Immunocore Holdings' Total Current Liabilities stood at $97.5 million in 2022, then jumped by 42.65% to $139.0 million in 2023, then jumped by 52.63% to $212.2 million in 2024, then increased by 16.27% to $246.7 million in 2025, then declined by 2.67% to $240.1 million in 2026.
• The last three Total Current Liabilities figures came in at $240.1 million (Q1 2026), $246.7 million (Q4 2025), and $170.4 million (Q3 2025), per Business Quant data.